Skip to content

Hydroxyamphetamine/Tropicamide

    DEA Class;  Rx

    Common Brand Names; Paremyd

    • Cycloplegics/Mydriatics
     

    Topical ophthalmic combination of an adrenergic agent and an anticholinergic agent
    Used for mydriasis in routine diagnostic procedures and in conditions where short-term pupil dilation desired
    Provides diminished pupil responsiveness to light, facilitating ophthalmoscopy

    Indicated for mydriasis induction in routine diagnostic procedures and conditions where short-term pupil dilation is desired.

    Hypersensitivity to product components

    Known or suspected angle-closure glaucoma, presence of a shallow anterior chamber unless gonioscopic observation of the chamber angle is possible; presence of narrow angle where pupil dilation may precipitate angle-closure glaucoma

    • Tachycardia
    • Pallor
    • Headache
    • Parasympathetic stimulation
    • Transient stinging
    • Dry mouth
    • Nausea
    • Vomiting
    • Allergic reactions
    • Blurred vision
    • Photophobia with or without corneal staining
    • Increased IOP
    • Muscle rigidity

    Monitor patients with cardiac disorders, diabetes mellitus, hypertension or hyperthyroidism

    May cause increased intraocular pressure (use with caution in patients with glaucoma)

    Possibility of undiagnosed glaucoma should be considered

    The elderly may experience intraocular pressure increase following use; use caution

    Pregnancy Category: C

    Lactation: Unknown if excreted in breast milk, use caution

    Adults

    2 drops/procedure per affected eye.

    Geriatric

    2 drops/procedure per affected eye.

    Adolescents

    Safety and efficacy have not been established.

    Children

    Safety and efficacy have not been established.

    Infants

    Safety and efficacy have not been established.

    Neonates

    Safety and efficacy have not been established.

    Hydroxyamphetamine hydrobromide/Tropicamide

    ophthalmic solution

    • 1%/0.25%